News

/
/
/
Second pilot rapid assessment on ‘Renal denervation systems for treatment-resistant hypertension’

Second pilot rapid assessment on ‘Renal denervation systems for treatment-resistant hypertension’

The purpose of the assessment is to assess the effectiveness and safety of renal denervation systems for patients who suffer from treatment-resistant hypertension compared to standard of care (no treatment, additional pharmacological treatment, device-based hypertension therapy and sham treatment).

Final version of the assessment was published in December 2013

Below is the documentation provided by the Joint Assessment authoring team:

Project plan
Summary document of comments and author’s replies to the review

Renal Denervation Systems for treatment-resistant hypertension_Rapid REA_Final_Dec 2013
WP5 Strand B_2nd pilot_Comments tables
WP5 Strand B_2nd pilot_Project Plan

This website uses cookies to ensure you get the best experience on our website. By using the website you agree to our Privacy Policy and our Terms of Use.